HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Interpretive Summary Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nafikov, R. A. Articles by Beitz, D. C. Search for Related Content PubMed PubMed Citation Articles by Nafikov, R. A. Articles by Beitz, D. C.

Prevention of Fatty Liver in Transition Dairy Cows by Subcutaneous Injections of Glucagon¹

R. A. Nafikov^*, B. N. Ametaj^*,2, G. Bobe^*, K. J. Koehler, J. W. Young^* and D. C. Beitz^*,3

^* Department of Animal Science, and
Department of Statistics, Iowa State University, Ames 50011-3150

³ Corresponding author: dcbeitz{at}iastate.edu

The main objective of this study was to test the extent to which injecting glucagon subcutaneously for 14 d beginning at d 2 postpartum would prevent fatty liver development in transition dairy cows. Twenty-four multiparous Holstein cows were fed 6 kg of cracked corn in addition to their standard diet during the last 30 d of a dry period to induce postpartum development of fatty liver. Glucagon at either 7.5 or 15 mg/d or saline (control) was injected subcutaneously 3 times daily for 14 d beginning at d 2 postpartum. Glucagon at 15 mg/ d prevented liver triacylglycerol accumulation in postpartum dairy cows. Glucagon at 7.5 mg/d showed potential for fatty liver prevention. Glucagon increased concentration of plasma glucose and insulin and decreased plasma nonesterified fatty acid concentrations. No effects of glucagon were detected on plasma ß-hydroxybutyrate concentrations. Glucagon affected neither feed intake nor milk production. Moreover, milk composition was not altered by glucagon. Milk urea N concentrations decreased, and plasma urea N concentrations tended to decrease during glucagon administration, indicating that glucagon may improve protein use. Liver glycogen concentrations were not affected by glucagon. No significant differences in body condition scores were detected among treatments throughout the study. These results indicate that subcutaneous glucagon injections can prevent fatty liver in transition dairy cows without causing major production and metabolite disturbances.

Key Words: dairy cow • fatty liver • glucagon • prevention

This article has been cited by other articles:

				S. Ali and D. J. Drucker Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E415 - E421. [Abstract] [Full Text] [PDF]

				M. A. Osman, P. S. Allen, N. A. Mehyar, G. Bobe, J. F. Coetzee, K. J. Koehler, and D. C. Beitz Acute Metabolic Responses of Postpartal Dairy Cows to Subcutaneous Glucagon Injections, Oral Glycerol, or Both J Dairy Sci, September 1, 2008; 91(9): 3311 - 3322. [Abstract] [Full Text] [PDF]

				S. Hachenberg, C. Weinkauf, S. Hiss, and H. Sauerwein Evaluation of classification modes potentially suitable to identify metabolic stress in healthy dairy cows during the peripartal period J Anim Sci, August 1, 2007; 85(8): 1923 - 1932. [Abstract] [Full Text] [PDF]